Back

Assessment of three-dimensional echocardiography as a diagnostic tool for detecting chemotherapy-induced cardiotoxicity

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic Heart Failure – Pathophysiology and Mechanisms Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Savvas Grigoriadis

General Hospital of Veria, Veria (Greece)

40 More presentations in this session

Presentation thumbnail
Relationship between functional capacity, haemodynamic response to exercise and quality of life in chronic heart failure
Miss S. Fatrin (Newcastle Upon Tyne, GB)
Abstract
Presentation thumbnail
Rationale and design of RHYTHM-HF: a novel observational study to investigate the role of arrhythmias and cause of death in heart failure utilising injectable cardiac monitors and autopsy examinations
Doctor S. Beggs (Glasgow, GB)
Abstract
Presentation thumbnail
Heterogeneity of cardiac macrophages in patients with of ischemic ADHF
Miss E. Kruchinkina (Tomsk, RU)
Abstract
Presentation thumbnail
Sex-specific biomarker profiles underlying Heart Failure development: a sub-study of the HOMAGE (Heart OMics in AGEing) consortium
Doctor A. Raafs (Eindhoven, NL)
Abstract Slides
Presentation thumbnail
Functional mitral regurgitation in pts with HFrEF, HFmrEF and HFpEF: the good, the bad and the ugly ?
Doctor M. Vanderheyden (Aalst, BE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources